Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | ANPEP | P15144 | 1/20 | 0.30 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30595606 | 0.84 | KDM4E (0.32) | — | |
| SCHEMBL432448 | 0.79 | — | — | |
| SCHEMBL805219 | 0.79 | — | — | |
| SCHEMBL12155774 | 0.79 | — | — | |
| SCHEMBL29790830 | 0.79 | ALDH1A1 (0.42) | — | |
| SCHEMBL9343006 | 0.77 | SMN1; SMN2 (0.38) | — | |
| SCHEMBL8829580 | 0.77 | — | — | |
| SCHEMBL28263469 | 0.77 | — | — | |
| Rubidium SCHEMBL9635582 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL3290648 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115227819-B | Self-oxygen-generating nano-particle for mediating photodynamic inhibition of skin photoaging and preparation method and application thereof | 徐州医科大学附属医院 | 2023-08-29 | — | — | CN | claimed |
| CN-119630394-A | Chelating agents for cancer treatment | 普雷高治疗有限公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-115068468-B | Carboxylic aromatic amides as bradykinin B1 receptor antagonists | 拜耳制药股份公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-115557907-B | 2,4, 5-Trisubstituted 1,2, 4-triazolones as DHODH inhibitors | 拜耳股份有限公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-113260382-B | Cell inhibitory conjugates containing integrin ligands | 拜耳医药股份有限公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-114466850-B | [1,2,4] Triazolo [1,5-C ] quinazolin-5-amine | 拜耳股份有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-118556062-A | Compounds, pharmaceutical compositions and methods for treating, preventing or managing hyperproliferative disorders | 文赛克斯制药有限责任公司 | 2024-08-27 | — | — | CN | disclosed |
| CN-115137726-B | Carboxylic aromatic amides as bradykinin B1 receptor antagonists | 拜耳制药股份公司 | 2024-08-13 | — | — | CN | disclosed |
| CN-118354796-A | Compounds, pharmaceutical compositions and methods for treating, preventing or managing hyperproliferative disorders | 文赛克斯制药有限责任公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-113348165-B | 1,2, 4-Triazin-3 (2H) -one compounds for the treatment of hyperproliferative diseases | 拜耳股份有限公司 | 2024-06-25 | — | — | CN | disclosed |
| US-20180104185-A1 | LIQUID COMPOSITIONS CAPABLE OF FOAMING AND INCLUDING ACTIVE AGENTS, AND METHODS FOR MAKING OR DEVELOPING SAME | MIKA PHARMA GMBH | 2018-04-19 | — | — | US | disclosed |
| US-9693956-B2 | Liquid compositions capable of foaming and including active agents, and methods for making or developing same | MIKA PHARMA GMBH | 2017-07-04 | — | — | US | disclosed |
| EP-2387391-B1 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA PHARMA GES FÜR DIE ENTW UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH (DE) | 2017-01-11 | — | — | EP | disclosed |
| US-20160022579-A1 | Liquid Compositions Capable of Foaming and Including Active Agents, and Methods for Making or Developing Same | MIKA PHARMA GMBH | 2016-01-28 | — | — | US | disclosed |
| US-9005626-B2 | Liquid compositions capable of foaming and including active agents, and methods for making or developing same | MIKA PHARMA GMBH (DE) | 2015-04-14 | — | — | US | disclosed |
| EP-2387391-A2 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH (DE) | 2011-11-23 | — | — | EP | disclosed |
| US-20110269704-A1 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA PHARMA GESELLSCHAFT FUR DIE ENTWICKLUNG UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH (DE) | 2011-11-03 | — | — | US | disclosed |
| WO-2011009436-A9 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA PHARMA GESELLSCHAFT FÜR DIE ENTWICKLUNG UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH (DE) | 2011-03-31 | — | — | WO | disclosed |
| US-20110059117-A1 | Liquid Compositions Capable of Foaming and Including Active Agents, and Methods for Making or Developing Same | MIKA PHARMA GMBH (DE) | 2011-03-10 | — | — | US | disclosed |
| WO-2011009436-A2 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA PHARMA GESELLSCHAFT FÜR DIE ENTWICKLUNG UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH (DE) | 2011-01-27 | — | — | WO | disclosed |